ADAR1 Capital Management’s Q32 Bio QTTB Stock Holding History

ADAR1 Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$225K	Buy	35,000 +15,000	+75%	+$71.3K	0.01%	256
2025 Q4	$66.4K	Buy	+20,000	New	+$56.5K	﹤0.01%	262
2024 Q4	–	Sell	-64,245	Closed	-$2.87M	–	310
2024 Q3	$2.87M	Sell	64,245 -92,259	-59%	-$3.39M	0.47%	41
2024 Q2	$2.81M	Sell	156,504 -31,063	-17%	-$743K	0.53%	30
2024 Q1	$3.2M	Buy	187,567 +171,252	+1,050%	+$2.36M	0.73%	26
2023 Q4	$179K	Buy	+16,315	New	+$239K	0.06%	84

Other funds holding QTTB

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mackenzie Financial

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return